Skip to content

Relation of Prajnaparadha(Intellectual blasphemy) in Amlapiitta (hyperacidity)

Critical Study on Prajnaparadha as a Principal Etiological Factor for Manifestation of Disease w.s.r. to Amlapitta - cspefa

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/01/017242
Enrollment
60
Registered
2019-01-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K319- Disease of stomach and duodenum, unspecified

Interventions

Intervention1: Laghusutashekhara Rasa and Sattvavajayachikitasa : Kalpana Vati (Tablet) Dose 1Tab(250mg)twice a day Route of administration Oral Time of administration In middle of meal (Samanakala)

Sponsors

IPGT RA GAU Jamnagar Gujarat Indias
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients will be selected on the basis of classical signs and symptoms of Amlapitta. 1. Age group- 18 to 50 years. 2. Patients having sign and symptoms of Amlapitta along with history of Prajnaparadha.

Exclusion criteria

Exclusion criteria: 1.Age of patient less than 18 years and more than 50 years. 2.Patients having history of sever gastritis or peptic ulcer. 3.Patients having major psychological disorders. 4.Patients having major illness like cardiac diseases, diabetes mellitus etc, drug induced diseases & also the involvement of other systemic disorders.

Design outcomes

Primary

MeasureTime frame
Improvement will be assessed on the basis of relief found in cardinal symptoms of disease Progress in the signs and symptoms based on the standard pattern will be applied before and after treatment Timepoint: 4 weeks

Secondary

MeasureTime frame
Improvement will be assessed on the basis of relief found in cardinal symptoms of disease Progress in the signs and symptoms based on the standard pattern will be applied before and after treatment Timepoint: 4 weeks

Countries

India

Contacts

Public ContactDr Shubhangi Kamble

IPGT and RA

drshubhashre@gmail.com9428400109

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026